Federal Circuit Addresses Patent Eligibility Of Isolated DNA And Related Diagnostic Methods August 3, 2011
»»»The Federal Circuit’s Myriad decision was vacated and remanded to the Federal Circuit for further consideration in view of the Supreme Court’s Mayo decision. August 3, 2011
»»»In an August 16, 2012 Decision on remand, the Federal Circuit maintained its prior positions essentially as outlined in our Special Report. August 3, 2011
»»»On November 30, 2012, the U.S. Supreme Court agreed to review the Federal Circuit decision as to the isolated DNA product claims. August 3, 2011
U.S. Supreme Court Unanimously Confirms That Invalidity Can Only Be Proved In Court By Clear And Convincing Evidence June 15, 2011
U.S. Supreme Court Holds That The Bayh-Dole Act Does Not Automatically Divest Inventors Of Their Rights In Federally Funded Inventions June 15, 2011
U.S. Supreme Court Holds That Inducement Under §271(B) Requires Knowledge That Induced Acts Constitute Patent Infringement, And Adopts “Willful Blindness” Standard For Establishing Such Knowledge June 6, 2011
»»»On July 21, 2011, the USPTO issued a Notice of Proposed Rulemaking proposing to revise the materiality standard for the USPTO to define materiality in accordance with the standard announced in Therasense. June 6, 2011
»»»It has been reported that the Therasense parties will not petition the U.S. Supreme Court for review of the decision. June 6, 2011
Federal Circuit Approves Reissue Applications That Only Add Dependent Claims To An Issued Patent April 29, 2011
USPTO Announces Accommodations for Those Affected by the Recent Tragic Events in Japan March 22, 2011
Fee Deferral Program for U.S. Nonprovisional Applications Claiming Priority to U.S. Provisional Applications December 10, 2010
»»»This program has been extended, and will continue to be available until December 31, 2013. December 10, 2010
